ZS

ZS ZS is a management consulting & technology firm focused on transforming global healthcare & beyond

AI doesn’t fully address the complexities of building a SaaS platform in house. Instead of deciding whether to buy or bu...
06/02/2026

AI doesn’t fully address the complexities of building a SaaS platform in house.

Instead of deciding whether to buy or build the software they need, leading organizations are now choosing a hybrid approach. They’re using AI to automate processes enabled by vertical SaaS platforms to deliver operational efficiencies and accelerate business outcomes.

Here are the benefits: https://bit.ly/3SfZemc

Marketing mix modeling (MMM) was built for a slower, more stable world. Today’s environment demands faster decisions, gr...
06/02/2026

Marketing mix modeling (MMM) was built for a slower, more stable world. Today’s environment demands faster decisions, greater transparency and systems that learn continuously.

Agentic AI is transforming MMM from a retrospective reporting tool into a real-time decision system—one that combines data, structured reasoning and human judgment to improve outcomes and scale expertise across organizations.

Find out how leading teams are redesigning MMM: https://bit.ly/4xaHZTE

AI investments don’t fail loudly in commercial pharma. They fade into the background. When insights never reach the fiel...
06/02/2026

AI investments don’t fail loudly in commercial pharma. They fade into the background.

When insights never reach the field, ex*****on doesn’t change. That’s why leading GCCs are pushing intelligence directly into sales and marketing workflows: so strategy actually shows up in day-to-day work.

Here’s how they’re closing the ex*****on gap: https://bit.ly/4vh7AZ2

Your brand can lose the deal before the first click. In AI search, competitors can be named, compared and endorsed in th...
06/01/2026

Your brand can lose the deal before the first click. In AI search, competitors can be named, compared and endorsed in the generated answer while you’re invisible.

This GEO framework shows how to baseline your presence, reduce citation risk and build a continuous capability that compounds: https://bit.ly/4dTFQTc

Emerging pharma companies need technology foundations that can support launch needs today and scale with the business to...
06/01/2026

Emerging pharma companies need technology foundations that can support launch needs today and scale with the business tomorrow.

On this podcast, leaders discuss how biopharma teams can make early platform decisions, balance AI ambition with readiness and build technology roadmaps that help teams move from insight to action.

The conversation also explores how platforms like ZAIDYN® can help embed trusted intelligence into everyday workflows.

🎧 Listen now: https://bit.ly/43HtZ62

AI can speed up clinical drafting—but that’s not the end goal.The shift is to a data-centric model, where documents are ...
05/29/2026

AI can speed up clinical drafting—but that’s not the end goal.

The shift is to a data-centric model, where documents are a byproduct of structured clinical knowledge.

Here’s what’s working in AI-assisted clinical authoring today: https://bit.ly/4dEkZo7

AI has yet to improve decision quality for most Medicare Advantage plans. Faster analysis and better data haven’t change...
05/29/2026

AI has yet to improve decision quality for most Medicare Advantage plans. Faster analysis and better data haven’t changed how plan design decisions get made.

Teams still rely on episodic reviews and fragmented inputs while bids lock in high-stakes choices around benefits, enrollment and profitability.

Here’s how to use AI to shape decision-making: https://bit.ly/4a2vvDn

The “SaaSpocalypse” assumes enterprise software is mostly code. In reality, the durable cost and risk sit in architectur...
05/29/2026

The “SaaSpocalypse” assumes enterprise software is mostly code. In reality, the durable cost and risk sit in architecture, institutional knowledge and operating discipline. That’s why many build‑it‑yourself bets underestimate total exposure. See the full argument: https://bit.ly/4fVey1k

Insights from the ZAIDYN® Biopharma Leadership Exchange show that many emerging biotech organizations are shifting towar...
05/28/2026

Insights from the ZAIDYN® Biopharma Leadership Exchange show that many emerging biotech organizations are shifting toward platform-led commercial data foundations—rather than assembling fragmented point solutions for each capacity.

See how Kalvista and other biopharma companies are building the right commercial foundation to support a successful launch: https://bit.ly/4dDlrTL

Thank you to everyone who met with ZS at Bio-IT World 2026. There was one resounding theme from our conversations: The p...
05/27/2026

Thank you to everyone who met with ZS at Bio-IT World 2026. There was one resounding theme from our conversations: The practical realities of applying AI across the R&D life cycle are too critical to miss.

AI remains in a “prototype” phase—teams are building quickly, but scaling is the real challenge. That shift requires:
➡️ Moving prototypes to enterprise-ready solutions with strong governance and product ownership
➡️ Ensuring sustainability, deployment and regulatory readiness
➡️ Bringing structure to evaluate a crowded vendor landscape

If you didn’t get a chance to meet with us on site, we’d still love to connect: https://bit.ly/4v8zp5O

Address

Evanston, IL

Telephone

+18474923600

Website

Alerts

Be the first to know and let us send you an email when ZS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ZS:

Shortcuts

Share